Tekla Capital Management as of June 30, 2018
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 180 positions in its portfolio as reported in the June 2018 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 5.5 | $146M | 2.1M | 70.84 | |
| Amgen (AMGN) | 4.9 | $129M | 701k | 184.59 | |
| Biogen Idec (BIIB) | 4.5 | $117M | 404k | 290.24 | |
| Johnson & Johnson (JNJ) | 4.1 | $108M | 893k | 121.34 | |
| UnitedHealth (UNH) | 4.0 | $104M | 425k | 245.34 | |
| Celgene Corporation | 3.8 | $99M | 1.3M | 79.42 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.8 | $99M | 582k | 169.96 | |
| Pfizer (PFE) | 3.2 | $86M | 2.4M | 36.28 | |
| Illumina (ILMN) | 3.0 | $80M | 285k | 279.29 | |
| Merck & Co (MRK) | 3.0 | $78M | 1.3M | 60.70 | |
| Mylan Nv | 2.3 | $60M | 1.7M | 36.14 | |
| Alexion Pharmaceuticals | 2.1 | $54M | 438k | 124.15 | |
| Regeneron Pharmaceuticals (REGN) | 1.9 | $51M | 146k | 344.99 | |
| Abbvie (ABBV) | 1.8 | $48M | 514k | 92.65 | |
| Incyte Corporation (INCY) | 1.6 | $43M | 645k | 67.00 | |
| Allergan | 1.6 | $42M | 249k | 166.72 | |
| Abbott Laboratories (ABT) | 1.4 | $38M | 627k | 60.99 | |
| Medtronic (MDT) | 1.4 | $36M | 424k | 85.61 | |
| Bristol Myers Squibb (BMY) | 1.4 | $36M | 651k | 55.34 | |
| Eli Lilly & Co. (LLY) | 1.3 | $33M | 390k | 85.33 | |
| Thermo Fisher Scientific (TMO) | 1.2 | $32M | 153k | 207.14 | |
| Humana (HUM) | 1.2 | $31M | 105k | 297.63 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $31M | 235k | 132.18 | |
| IDEXX Laboratories (IDXX) | 1.1 | $28M | 130k | 217.94 | |
| AstraZeneca (AZN) | 1.0 | $27M | 779k | 35.11 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $27M | 270k | 98.24 | |
| Teva Pharmaceutical Industries (TEVA) | 1.0 | $26M | 1.1M | 24.32 | |
| Anthem (ELV) | 1.0 | $26M | 111k | 238.03 | |
| CVS Caremark Corporation (CVS) | 0.9 | $24M | 367k | 64.35 | |
| SPDR S&P Biotech (XBI) | 0.9 | $24M | 251k | 95.19 | |
| Stryker Corporation (SYK) | 0.9 | $23M | 137k | 168.86 | |
| Centene Corporation (CNC) | 0.9 | $23M | 185k | 123.21 | |
| Novartis (NVS) | 0.8 | $22M | 296k | 75.54 | |
| Sage Therapeutics (SAGE) | 0.8 | $23M | 144k | 156.53 | |
| Danaher Corporation (DHR) | 0.7 | $19M | 193k | 98.68 | |
| Jazz Pharmaceuticals (JAZZ) | 0.7 | $19M | 111k | 172.30 | |
| Seattle Genetics | 0.7 | $19M | 279k | 66.39 | |
| Aetna | 0.7 | $18M | 97k | 183.50 | |
| Omega Healthcare Investors (OHI) | 0.7 | $18M | 580k | 31.00 | |
| Sabra Health Care REIT (SBRA) | 0.6 | $16M | 725k | 21.73 | |
| Boston Scientific Corporation (BSX) | 0.6 | $15M | 458k | 32.70 | |
| GlaxoSmithKline | 0.6 | $15M | 359k | 40.31 | |
| Amicus Therapeutics (FOLD) | 0.5 | $14M | 875k | 15.62 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $13M | 141k | 94.20 | |
| McKesson Corporation (MCK) | 0.5 | $13M | 99k | 133.40 | |
| Zimmer Holdings (ZBH) | 0.5 | $13M | 119k | 111.44 | |
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $13M | 130k | 98.49 | |
| Becton, Dickinson and (BDX) | 0.5 | $13M | 53k | 239.55 | |
| Medical Properties Trust (MPW) | 0.5 | $12M | 859k | 14.04 | |
| Welltower Inc 6.50% pfd prepet | 0.5 | $12M | 200k | 59.45 | |
| Senior Housing Properties Trust | 0.4 | $12M | 647k | 18.09 | |
| Intuitive Surgical (ISRG) | 0.4 | $11M | 24k | 478.47 | |
| Bluebird Bio (BLUE) | 0.4 | $11M | 72k | 156.94 | |
| Diplomat Pharmacy | 0.4 | $11M | 439k | 25.56 | |
| Acadia Healthcare (ACHC) | 0.4 | $11M | 272k | 40.91 | |
| Fibrogen (FGEN) | 0.4 | $11M | 178k | 62.60 | |
| Pieris Pharmaceuticals | 0.4 | $11M | 2.1M | 5.07 | |
| Crispr Therapeutics (CRSP) | 0.4 | $11M | 178k | 58.76 | |
| Endo International | 0.4 | $10M | 1.1M | 9.43 | |
| Adaptimmune Therapeutics (ADAP) | 0.4 | $10M | 856k | 11.87 | |
| Baxter International (BAX) | 0.4 | $9.9M | 134k | 73.84 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $10M | 72k | 139.54 | |
| Edwards Lifesciences (EW) | 0.4 | $9.6M | 66k | 145.58 | |
| Merus N V (MRUS) | 0.4 | $9.4M | 414k | 22.76 | |
| Exelixis (EXEL) | 0.3 | $9.2M | 428k | 21.52 | |
| Nektar Therapeutics (NKTR) | 0.3 | $9.2M | 189k | 48.83 | |
| Blueprint Medicines (BPMC) | 0.3 | $9.3M | 146k | 63.48 | |
| LTC Properties (LTC) | 0.3 | $9.0M | 210k | 42.74 | |
| Cellectis S A (CLLS) | 0.3 | $9.0M | 318k | 28.29 | |
| Medicines Company | 0.3 | $8.8M | 239k | 36.70 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.3 | $8.5M | 13M | 0.65 | |
| Beigene | 0.3 | $8.4M | 55k | 153.73 | |
| Express Scripts Holding | 0.3 | $8.2M | 107k | 77.21 | |
| Acceleron Pharma | 0.3 | $8.3M | 171k | 48.52 | |
| AmerisourceBergen (COR) | 0.3 | $7.9M | 93k | 85.27 | |
| Galapagos Nv- (GLPG) | 0.3 | $8.0M | 87k | 92.18 | |
| Hca Holdings (HCA) | 0.3 | $7.7M | 75k | 102.60 | |
| Esperion Therapeutics (ESPR) | 0.3 | $7.4M | 189k | 39.19 | |
| Sanofi-Aventis SA (SNY) | 0.3 | $7.2M | 180k | 40.01 | |
| Alkermes (ALKS) | 0.3 | $7.0M | 171k | 41.16 | |
| CIGNA Corporation | 0.3 | $6.9M | 41k | 169.94 | |
| Wright Medical Group Nv | 0.3 | $6.9M | 267k | 25.96 | |
| Epizyme | 0.2 | $6.6M | 485k | 13.55 | |
| Novo Nordisk A/S (NVO) | 0.2 | $6.3M | 136k | 46.12 | |
| Physicians Realty Trust | 0.2 | $6.2M | 391k | 15.94 | |
| ResMed (RMD) | 0.2 | $6.1M | 59k | 103.58 | |
| Shire | 0.2 | $6.1M | 36k | 168.79 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $5.9M | 77k | 76.87 | |
| Ventas (VTR) | 0.2 | $5.6M | 99k | 56.95 | |
| Tenet Healthcare Corporation (THC) | 0.2 | $5.5M | 165k | 33.57 | |
| Puma Biotechnology (PBYI) | 0.2 | $4.9M | 83k | 59.16 | |
| Editas Medicine (EDIT) | 0.2 | $4.9M | 138k | 35.83 | |
| Flamel Technologies Sa | 0.2 | $5.0M | 815k | 6.13 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $4.7M | 41k | 113.16 | |
| Masimo Corporation (MASI) | 0.2 | $4.7M | 48k | 97.65 | |
| Foamix Pharmaceuticals | 0.2 | $4.7M | 930k | 5.01 | |
| Valeant Pharmaceuticals Int | 0.2 | $4.5M | 192k | 23.24 | |
| Intellia Therapeutics (NTLA) | 0.2 | $4.6M | 167k | 27.36 | |
| Albireo Pharma | 0.2 | $4.4M | 125k | 35.50 | |
| Array BioPharma | 0.2 | $4.3M | 256k | 16.78 | |
| Tesaro | 0.2 | $4.2M | 95k | 44.47 | |
| Nevro (NVRO) | 0.2 | $4.2M | 53k | 79.85 | |
| Arena Pharmaceuticals | 0.2 | $4.1M | 94k | 43.60 | |
| Ovid Therapeutics (OVID) | 0.2 | $4.2M | 536k | 7.80 | |
| New Senior Inv Grp | 0.1 | $4.0M | 529k | 7.57 | |
| Verona Pharma Plc ads (VRNA) | 0.1 | $3.8M | 275k | 13.75 | |
| Clovis Oncology | 0.1 | $3.4M | 75k | 45.46 | |
| Portola Pharmaceuticals | 0.1 | $3.4M | 90k | 37.76 | |
| Coherus Biosciences (CHRS) | 0.1 | $3.4M | 241k | 14.00 | |
| Ionis Pharmaceuticals (IONS) | 0.1 | $3.5M | 83k | 41.67 | |
| Zoetis Inc Cl A (ZTS) | 0.1 | $3.0M | 36k | 85.18 | |
| Tetraphase Pharmaceuticals | 0.1 | $3.1M | 859k | 3.57 | |
| Teligent | 0.1 | $3.1M | 906k | 3.46 | |
| Argenx Se (ARGX) | 0.1 | $3.2M | 39k | 82.86 | |
| Aerpio Pharmaceuticals | 0.1 | $3.2M | 765k | 4.15 | |
| Varian Medical Systems | 0.1 | $3.0M | 26k | 113.74 | |
| Pra Health Sciences | 0.1 | $3.0M | 33k | 93.35 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $2.8M | 468k | 6.00 | |
| Ascendis Pharma A S (ASND) | 0.1 | $2.9M | 44k | 66.52 | |
| Welltower Inc Com reit (WELL) | 0.1 | $2.9M | 46k | 62.69 | |
| Charles River Laboratories (CRL) | 0.1 | $2.5M | 23k | 112.26 | |
| Perrigo Company (PRGO) | 0.1 | $2.7M | 37k | 72.92 | |
| Akebia Therapeutics (AKBA) | 0.1 | $2.7M | 267k | 9.98 | |
| Horizon Pharma | 0.1 | $2.7M | 163k | 16.56 | |
| Affimed Therapeutics B V | 0.1 | $2.7M | 1.6M | 1.65 | |
| Evolent Health (EVH) | 0.1 | $2.6M | 123k | 21.05 | |
| Global Blood Therapeutics In | 0.1 | $2.7M | 59k | 45.19 | |
| Henry Schein (HSIC) | 0.1 | $2.3M | 31k | 72.64 | |
| Ardelyx (ARDX) | 0.1 | $2.4M | 639k | 3.70 | |
| Cymabay Therapeutics | 0.1 | $2.3M | 170k | 13.42 | |
| Steris | 0.1 | $2.4M | 22k | 105.03 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.1 | $2.5M | 7.0M | 0.35 | |
| Healthcare Realty Trust Incorporated | 0.1 | $2.0M | 68k | 29.07 | |
| Revance Therapeutics (RVNC) | 0.1 | $2.1M | 78k | 27.45 | |
| Dermira | 0.1 | $2.2M | 234k | 9.20 | |
| Innoviva (INVA) | 0.1 | $2.2M | 162k | 13.80 | |
| Ra Pharmaceuticals | 0.1 | $2.2M | 220k | 9.95 | |
| Achillion Pharmaceuticals | 0.1 | $1.7M | 616k | 2.83 | |
| Loxo Oncology | 0.1 | $1.8M | 10k | 173.47 | |
| Spark Therapeutics | 0.1 | $1.8M | 22k | 82.78 | |
| Sangamo Biosciences (SGMO) | 0.1 | $1.7M | 121k | 14.20 | |
| Teleflex Incorporated (TFX) | 0.1 | $1.7M | 6.4k | 268.22 | |
| Smith & Nephew (SNN) | 0.1 | $1.7M | 44k | 37.53 | |
| Amarin Corporation (AMRN) | 0.1 | $1.5M | 478k | 3.09 | |
| Therapeuticsmd | 0.1 | $1.5M | 234k | 6.24 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $1.5M | 164k | 9.20 | |
| Zogenix | 0.1 | $1.6M | 35k | 44.21 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $1.5M | 219k | 6.72 | |
| Ac Immune Sa (ACIU) | 0.1 | $1.6M | 172k | 9.30 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $1.4M | 94k | 15.27 | |
| Uniqure Nv (QURE) | 0.1 | $1.4M | 38k | 37.81 | |
| Healthcare Tr Amer Inc cl a | 0.1 | $1.2M | 46k | 26.96 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $1.4M | 200k | 7.02 | |
| NuVasive | 0.0 | $1.0M | 20k | 52.15 | |
| HCP | 0.0 | $1.2M | 46k | 25.82 | |
| Newlink Genetics Corporation | 0.0 | $976k | 205k | 4.76 | |
| Mallinckrodt Pub | 0.0 | $1.2M | 62k | 18.66 | |
| Nanostring Technologies (NSTGQ) | 0.0 | $1.0M | 74k | 13.68 | |
| Hologic (HOLX) | 0.0 | $777k | 20k | 39.75 | |
| Community Health Systems (CYH) | 0.0 | $677k | 204k | 3.32 | |
| Novavax | 0.0 | $765k | 571k | 1.34 | |
| LeMaitre Vascular (LMAT) | 0.0 | $909k | 27k | 33.48 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.0 | $826k | 159k | 5.20 | |
| Clearside Biomedical (CLSD) | 0.0 | $884k | 83k | 10.69 | |
| Molecular Templates | 0.0 | $754k | 144k | 5.23 | |
| DepoMed | 0.0 | $420k | 63k | 6.67 | |
| Bellicum Pharma | 0.0 | $443k | 60k | 7.38 | |
| Arca Biopharma | 0.0 | $454k | 811k | 0.56 | |
| Livanova Plc Ord (LIVN) | 0.0 | $628k | 6.3k | 99.89 | |
| Rmr Group Inc cl a (RMR) | 0.0 | $584k | 7.4k | 78.48 | |
| Global Medical Reit (GMRE) | 0.0 | $650k | 73k | 8.86 | |
| Iovance Biotherapeutics (IOVA) | 0.0 | $427k | 33k | 12.79 | |
| Cardinal Health (CAH) | 0.0 | $308k | 6.3k | 48.89 | |
| Agios Pharmaceuticals (AGIO) | 0.0 | $237k | 2.8k | 84.34 | |
| Theravance Biopharma (TBPH) | 0.0 | $183k | 8.1k | 22.64 | |
| Nucana Plc american depositary shares | 0.0 | $187k | 9.8k | 19.04 | |
| Alliqua Biomedical | 0.0 | $338k | 165k | 2.05 | |
| Celldex Therapeutics | 0.0 | $53k | 106k | 0.50 | |
| Quorum Health | 0.0 | $119k | 24k | 5.02 | |
| Jounce Therapeutics | 0.0 | $78k | 10k | 7.70 |
